Department of Food Science and Technology, Faculty of Agriculture, Ferdowsi University of Mashhad, Mashhad, Iran.
Department of Medicinal Chemistry, School of Pharmacy, Mashhad University of Medical Sciences, Mashhad, Iran.
Sci Rep. 2024 May 31;14(1):12540. doi: 10.1038/s41598-024-63110-y.
Cyclosporine A (CyA) holds significant importance as a strategic immunosuppressive drug for organ transplant patients. In this study, we aimed to produce pure and cost-effective Cyclosporine A (CyA) by fermenting a culture medium containing dairy sludge, using Tolypocladium inflatum PTCC 5253. Following the fermentation stage, ethyl acetate extraction and fast protein liquid chromatography were employed for sample purification. The initial evaluation of the effectiveness of CyA obtained from these processes was performed through bioassay, wherein the antimicrobial clear zone diameter was found to be larger compared to the sample obtained from the fermentation culture. The concentration of CyA was determined using high-performance liquid chromatography, yielding values of 334 mg/L, 456 mg/L, and 578 mg/L for the fermented, extracted, and purified samples, respectively. Further analysis utilizing liquid chromatography tandem mass spectrometry (LC/MS/MS) confirmed a purity of 91.9% and proper agreement with the standard sample based on the ion intensity of Z/m 1205. To validate the structure of CyA, nuclear magnetic resonance spectroscopy, Fourier-transform infrared (FT-IR), and Raman spectroscopy were employed. X-ray diffraction and differential scanning calorimetry analyses demonstrated that the purified CyA exhibited a crystal structure similar to the standard sample, characterized by two broad peaks at 2θ = 9° and 20°, and comparable glass transition temperatures (57-68 °C for the purified sample; 53-64 °C for the standard sample). Dynamic light scattering analysis confirmed a uniform particle size distribution in both the purified and standard samples. The zeta potentials of the purified and standard samples were determined to be - 25.8 ± 0.16 and - 23.63 ± 0.12 mV, respectively. Our results demonstrate that dairy sludge can serve as a suitable culture medium for the production of (CyA).
环孢素 A(CyA)作为器官移植患者的重要战略免疫抑制剂具有重要意义。在这项研究中,我们旨在通过发酵含有乳泥的培养基,使用 Tolypocladium inflatum PTCC 5253 生产纯且具有成本效益的环孢素 A(CyA)。发酵后,采用乙酸乙酯萃取和快速蛋白质液相色谱法进行样品纯化。通过生物测定法对这些方法获得的 CyA 的效果进行了初步评估,发现其抗菌透明圈直径大于发酵培养物中获得的样品。使用高效液相色谱法测定 CyA 的浓度,分别得到发酵、提取和纯化样品的浓度为 334mg/L、456mg/L 和 578mg/L。进一步利用液相色谱串联质谱(LC/MS/MS)分析,确认纯度为 91.9%,并且基于 Z/m 1205 的离子强度与标准样品一致。为了验证 CyA 的结构,使用了核磁共振波谱、傅里叶变换红外(FT-IR)和拉曼光谱。X 射线衍射和差示扫描量热法分析表明,纯化的 CyA 表现出与标准样品相似的晶体结构,其特征在于在 2θ=9°和 20°处有两个宽峰,并且玻璃化转变温度相近(纯化样品为 57-68°C;标准样品为 53-64°C)。动态光散射分析证实了纯化和标准样品的粒径分布均匀。纯化和标准样品的zeta 电位分别为-25.8±0.16 mV 和-23.63±0.12 mV。我们的结果表明,乳泥可以作为生产(CyA)的合适培养基。